The order aims to fix problems with Medicare's drug price negotiation program by making it more transparent and effective, while preventing higher costs for seniors' insurance premiums
Healthcare centers will be required to provide affordable insulin and EpiPens to low-income people who have high insurance costs or no insurance
The government will make it easier for states to import cheaper prescription drugs from other countries while maintaining safety standards
The order calls for faster approval of generic drugs and alternatives to brand-name medications to increase competition and lower prices
New rules will increase transparency around pharmacy benefit managers (middlemen) to help ensure discounts are actually passed on to patients